secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0001437749-25-012731
Event type: m_and_a
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 2.03, 2.01, 2.02, 8.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision acquires heart failure device assets; Q1 revenue up 73% to $142k
--------------------------------------------------------------------------------

- Subsidiary Cardionomix buys patents/trademarks for Cardionomic's CPNS System (acute decompensated heart failure).
- Purchase price: 1M restricted VTAK shares plus a $1.5M promissory note (4% interest, 3-year maturity).
- Closing conditions include NYSE American listing approval; deal must close by July 21, 2025.
- Preliminary Q1 2025 revenue $142k vs $82k YoY (+73%).
- Company warns it needs additional financing to develop assets; dilution expected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000143774925012731/0001437749-25-012731-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000143774925012731/vtak20250415_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-012731

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer